SFM Co., Ltd. (“the Company”) hereby establishes the following Terms of Service (“these Terms”) for the health management application software “FLD HbA1c” provided via smartphone devices.

Article 1 (User)

1. These Terms apply to individuals who have legitimately downloaded FLD HbA1c to their own devices via the App Store and wish to use the services provided by the Company.

2. The App is licensed only to the individual who downloads it. Corporations and other organizations may not use this Service. Each user must register separately.

3. By downloading and using the App, the user is deemed to have agreed to these Terms.

4. Communication charges for downloading or using the App shall be borne by the user.

Article 2 (Definitions)

1. Terms used in these Terms shall have the following meanings:

(1) “Medical Information” means comprehensive information related to the diagnosis and treatment of diseases. The Service is intended only for general health promotion and management and shall not be used for medical diagnosis or treatment.

(2) “Apple Inc.” is not a party to these Terms but may terminate the service contract. Matters not specified here shall follow the Apple End User License Agreement.

3) “The Company” refers to SFM Co., Ltd., which holds all responsibility related to the Service, including claims, support, and intellectual property.

(4) “Supported Devices” include iPhone15 series and later. iPhone13Pro and 14Pro are usable but not recommended.

(5) “In-App Billing” refers to Apple Inc.’s billing system used in the App.

(6) “Recommended Identity Verification” suggests using Face ID to reduce risk.

(7) “Recommended Usage” includes launching the App, holding the device vertically, and positioning the face within the frame.

(8) “Recommended Time” is approximately 10 seconds, subject to conditions.

(9) “Estimate Data” includes HbA1c values. Within the HbA1c estimate range of 4.55 to 6.54, the value is displayed as a actual value rounded to the first decimal place (rounding at the second decimal place), and shown within the range of 4.6 to 6.5. If the estimate result is 6.55 or higher, it is displayed as “6.5 over. “If the mstimate result is 4.54 or lower, it is displayed as “4.6 under.” And, for reference, pulse and oxygen saturation.

(10) “Recommended Environment” includes Wi-Fi connection, sufficient lighting, and non-crowded space. Therefore, use in a moving vehicle or on a train is not recommended due to safety concerns and the possibility of camera shake affecting estimate accuracy. Estimate data is not recorded, so please use the app in an environment where the user can confirm the results on the screen. Use in backlit or direct sunlight conditions is not recommended; please change your position or move to a different location. Wearing regular eyeglasses or standard sunglasses for light shielding is acceptable during use. However, it is recommended not to wear large fashion sunglasses, masks, or hats. Pregnant individuals can use the app safely, as it does not emit any special light or sound that affects the human body.

Article 3 (Service Description)

1. FLD HbA1c is a proprietary health management application developed using advanced optical analysis technology.

2. The App uses the camera and computational functions of supported devices to display HbA1c values.

3. Estimate Data is not provided as Medical Information.

4. Users must follow the Recommended Usage Method.

5. Estimate Data disappears after a few seconds and is not stored.

6. The App does not use needles, collect blood, or emit special light/sound.

7. Pulse and oxygen saturation values are displayed as references.

8. All information is processed within the App, minimizing security risk.

9. The App is not age-restricted but is recommended for users aged 18 and above.

Article 4 (Registration)

1. A person wishing to use the Service (“Applicant”) may apply by agreeing to these Terms and providing certain information (“Registration Information”) in the manner specified by the Company.

2. The Company will determine whether to approve the registration based on its criteria and will notify the Applicant upon approval. Registration is considered complete upon this notification.

3. Upon completion of registration, a service usage agreement (“Service Agreement”) is established between the User and the Company.

4. The Company may refuse registration or re-registration without obligation to disclose the reason if:

(1) Any false, incorrect, or omitted information is provided; (2) The applicant is or is affiliated with antisocial forces; (3) The applicant previously violated a contract with the Company; (4) The applicant has had their eligibility suspended or revoked before; (5) The Company reasonably deems the registration inappropriate.

Article 5 (Changes to Registration Information)

Users shall promptly notify the Company of any changes to their Registration Information using the method specified by the Company.

Article 6 (Management of Password and User ID)

1. Users are responsible for managing their password and user ID related to the Service and must not share, lend, transfer, change the name, or sell them to third parties.

2. The Company shall not be liable for any damages arising from inadequate management, misuse, or use by third parties.

Article 7 (Fees)

1. Plans of the same grade are offered: (1) Plan : 30,000 JPY

2. In case of delayed payment, Users shall pay late charges at an annual rate of 14.6%.

Article 8 (Prohibited Conduct)

1. Users shall not: (1) Copy, modify, alter, or adapt the App; (2) Reproduce or disclose App programs to third parties; (3) Disrupt the operation of the Service; (4) Use content for non-Service purposes; (5) Transfer Service rights to third parties; (6) Cause damage to others or the Company; (7) Act against public order or laws; (8) Violate these Terms; (9) Use for medical diagnosis or treatment.

2. Users are liable for damages resulting from such actions.

3. The Company is not liable for inability to use the Service due to suspended or revoked eligibility unless caused by the Company’s intent or gross negligence.

Article 9 (Service Suspension)

The Company may suspend or interrupt all or part of the Service without prior notice if: (1) Urgent maintenance is required; (2) Operation becomes impossible due to technical issues; (3) Force majeure events occur; (4) The Company reasonably deems suspension necessary.

Article 10 (Intellectual Property)

1. Intellectual property rights for the Service belong to the Company or licensors.
2. Users represent and warrant that they get lawful rights to the data measured using the Service.
3. Users grant other users a non-exclusive, global, royalty-free license to use such data.
4. Users agree not to assert moral rights against the Company or successors.

Article 11 (Deregistration and Suspension)

1. The Company may, without prior notice, delete or hide estimate data, temporarily suspend use, or cancel registration of any User if: (1) The User
violates any provision of these Terms; (2) False information is found in the Registration
Information; (3) The User suspends payment, becomes insolvent, or is subject to bankruptcy, civil rehabilitation, corporate reorganization, special liquidation, or similar proceedings; (4) The Service is not used for six months or more; (5) The User does not respond to inquiries from the Company for more than 14 days; (6) The User falls under any of the items in Article 4.4; (7) The User engages in any conduct prohibited under Article 8.1; (8) The Company deems continued use or registration inappropriate.

2. In such cases, the User shall forfeit the benefit of time and immediately pay all obligations to the Company.

Article 12 (Service Period and Withdrawal)

1. The Service period shall be the term selected by the User.
2. Users may cancel the Service by completing the withdrawal procedure. If no withdrawal procedure is completed, the Service will be automatically renewed for the same term.

Article 13 (Disclaimer)

1. The Company shall not be liable for: (1) Damages caused to thirdparties by a User’s use of the Service; (2) Inability to use the Service due to reasons not
attributable to the Company.

2. The Company does not guarantee that the App will be compatible with all devices. (1) Even supported devices may not operate normally. (2) The App is developed for smartphones and not usable on tablets.

3. The Company does not guarantee the completeness, accuracy, certainty, or usefulness of any content or data obtained through the App.

4. The Company is not responsible for any damage to a device or virus infection caused by use of information or images from the App, unless due to intentional misconduct or gross negligence.

5. The App is not classified as a medical device under the Pharmaceuticals and Medical Devices Act of Japan.

6. The information provided by the App is for general health and lifestyle management reference only and not a substitute for professional medical advice.

7. Users agree to use the App under their own responsibility and in compliance with relevant laws.

Article 14 (Modifications and Termination)

1. The Company will strive to provide the latest version of the Service for improved convenience and reliability.
2. Minor changes such as bug fixes and updates will be noted on the official website or in general explanations.

3. Important changes will be announced on the official site or in the “New Features” section.
4. Changes affecting Users’ interests will be carefully considered and Users will be notified in advance.
5. The Company may terminate the Service at its discretion.
6. In such cases, the Company will notify Users in advance.

Article 15 (Confidentiality)

Users must treat as confidential any non-public information disclosed by the Company that is designated as confidential, unless prior written consent is obtained.

Article 16 (Handling of User Information)

1. User information will be handled in accordance with the Company’s Privacy Policy (FLD HbA1c Privacy Policy).

2. The Company may use and publish statistical data in a non-personally identifiable form at its discretion.

Article 17 (Amendment of Terms)

1. The Company may amend these Terms as deemed necessary.
2. In the previous cases, the Company will announce the implementation date and content via appropriate means.
3. Where legally required, the Company will obtain User consent through prescribed methods.
4. Renewal of service under Article 12 shall be deemed as acceptance of amended Terms.

Article 18 (Notices)

1. User inquiries and Company communications will be handled by methods
designated by the Company.

2. Notices sent to contact details in the Registration Information shall be deemed received by the User.

Article 19 (Transfer of Contractual Status)

1. Users may not transfer or dispose of their contractual rights or obligations without prior written consent from the Company.

2. If the Company transfers its business related to the Service, it may also transfer the contractual status, rights, obligations, and user information. Users consent to such transfers in advance.

Article 20 (Severability)

If any provision of these Terms is found invalid or unenforceable, the remaining provisions shall remain in full force and effect.

Article 21 (Governing Law and Jurisdiction)

1. These Terms and the Service Agreement shall be governed by the laws of Japan.
2. Any disputes arising from or related to these Terms shall be subject to the exclusive jurisdiction of the Tokyo District Court.

Supplementary Provision Effective: May 18th, 2025